央视网消息："十五五"规划建议中提出，加快建设健康中国，实施健康优先发展战略，推进全民健康数智化建设。眼下，各地都在积极探索落地的新路径， 广东深圳正通过自身科技研发优势，用人工智能等前沿技术来填补医疗短板。 攻克技术壁垒 医产研融合创新 这是一家国家高新技术企业和专精特新企业，研发人员正在调试他们最新研发的手术机器人。 睿心医疗创始人 郑凌霄：我们加了AI的深度学习的功能，大量地去训练。 郑凌霄告诉记者，过去，一般血管类的手术，医生需要拿着一根头发粗细的导丝，插入患者的血管内。这类手术对医生要求很高，人才缺口大。 医疗资源不平衡这个市场痛点，在郑凌霄团队看来，恰恰是企业的发力方向，他们果断将研发目标锁定在技术门槛高且专家资源紧缺的心血管手术上。经过 了5年的研发攻关，他们先后在硬件机械臂研发、核心算法训练上取得突破，并生产出了初代样机。 听到指令后，机器手臂开始摆动定位，同时将导丝插入指令血管内，动作流畅。但在实际手术中，这种操作却非常依赖医生的手感，医生可以感受导丝在血 管中行进时的阻力变化，从而调整操作手法与力度，但机器人并不具备这样的能力。 如何让机器人像人一样可以感受到导丝带来的力反馈？企业与中国科 ...

Masimo (NasdaqGS:MASI) Q3 2025 Earnings Call November 04, 2025 04:30 PM ET Speaker5Good afternoon, ladies and gentlemen, and welcome to the Masimo third quarter 2025 earnings conference call. The company's press release is available at www.masimo.com. At this time, all lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. I'm pleased to introduce Eli Kammerman, Masimo's Vice President of Business Development and Investor Rel ...

Third Quarter 2025 Earnings November 4, 2025 1 Safe Harbor Statement Executive Summary | Continuing Operations(1) | Continuing Operations(1) | Executive Summary | | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Non-GAAP results including new tariffs: | Non-GAAP results including new tariffs: | Revenue(2) | Revenue(2) | million grew 8% on a constant currency(3) | million grew 8% on a constant currency(3) | • | • | of $371 | of $3 ...

GRAND RAPIDS, Mich., Nov. 4, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that Rob Ball, CEO, will present at the upcoming Jefferies Global Healthcare Conference. The presentation will take place at 8:30 a.m. GMT / 3:30 a.m. EST on November 18, 2025. Event: Jefferies Global Healthcare Conference Date: Tuesday, November 18, 2025Time: 8:30 ...

Novanta (NasdaqGS:NOVT) Q3 2025 Earnings Call November 04, 2025 08:30 AM ET Speaker1Good morning. My name is Andrea, and I will be your conference operator today. At this time, I would like to welcome everyone to Novanta's third quarter 2025 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press ...

Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today is pleased to announce that its subsidiary, Neologics Bioscience Inc. (“Neologics”), has entered into a key service agreement (the “Agreement”) with GemPharmatech Corporation (“GemPharmatech”), a Delaware-based leading cont ...

Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today is pleased to announce that its subsidiary, Neologics Bioscience Inc. (“Neologics”), has entered into a key service agreement (the “Agreement”) with GemPharmatech Corporation (“GemPharmatech”), a Delaware-based leading cont ...

MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report third quarter 2025 financial results on Thursday, November 13, 2025. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Third Quarter Earnings Conference Call ...

The London Company, an investment management company, released “The London Company Small Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. US equities continued their rally in the third quarter, driven by the Fed rate cut, solid corporate earnings, and enthusiasm around AI. The small-cap portfolio appreciated 1.9% (2.4% net) in the third quarter, compared to the Russell 2000 Index’s 12.4% gain. Please review the fund’s top 5 holdings to gain insight into their ke ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional Shares) in the quarter, compared to a 5.05% gain for the Russell 3000 Health Care Index (benchmark) and an 8.18% gain for the Russell 3000 Index (the Index). The Fund performed similarly to the Benchmark this quarter. Solid stock selection was primarily offset by negative effects from active sub-industry allo ...